Navigation Links
Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology

, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.

This news release was distributed by PrimeNewswire, www.primenewswire.com

SOURCE: Generex Biotechnology Corp.

Generex
Shayne Gilliatt
800-391-6755
416-364-2551

CEOcast, Inc.
Andrew Hellman
212-732-4300



'"/>




Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
8. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
9. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
Post Your Comments:
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... WASHINGTON , Aug. 29, 2014 Diseases ... a generation ago are returning. Measles was declared ... cases in 2014 as of August 15—the highest incidence ... public health department declared whooping cough a problem ... children are getting sick and dying from these preventable ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... Continues Biocatalysis Business Growth With a Further $4m R&D Investment -- CRAIGAVON, Northern Ireland, October 7, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... N.J., Oct. 7 Novartis Pharmaceuticals Corporation today ... Gilenya™ (fingolimod) 0.5 mg daily, a first-line oral ... was approved by the US Food and Drug ... For people with MS and healthcare professionals seeking ...
Cached Medicine Technology:Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 2Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 3Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 4Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 5Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 6Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 7Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 2Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 3Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 4Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 5Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 6Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 7
(Date:8/29/2014)... 2014 Evolutions Medical & Day Spa ... Santa Barbara News-Press Readers’ Choice 2014 poll. This is ... poll as Best Medical Spa. The 2014 Readers’ Choice ... about Evolutions Medical Spa recognition: , “Not only does ... as a top-notch, cutting-edge medical spa as well. Founder ...
(Date:8/29/2014)... 2014 Sansego is an ... interactive online community, and a range of personalized coaching ... the way to professional athletes. Crowie has brought together ... with him throughout the majority of his triathlon career. ... the triathlon public. , Sansego provides the following:, ...
(Date:8/29/2014)... 2014 September yoga month was created ... yoga and its health benefits. To support this Ekhart ... their "Yoga Month Challenge" , This 4 week guided ... and experienced yogis practice yoga regularly from their own ... Challenge ' is suitable for all levels, and the ...
(Date:8/29/2014)... New Delhi (PRWEB) August 29, 2014 ... a new service named ‘Remove Bad Reviews’. This service ... tough time on account of negative reviews against them. ... should not fail to deliver the committed results to ... serious study about the world of internet marketing. , ...
(Date:8/29/2014)... Senior Independence has promoted Mica Rees ... Rees has been with Senior Independence since March 2013 ... wholly owned subsidiary of Ohio Presbyterian Retirement Services ... including personalized home health care (e.g., physical therapy), hospice ... adult day centers. , Rees will continue to move ...
Breaking Medicine News(10 mins):Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:ReputationChief.Com Announces a New Service ‘Remove Bad Reviews’ 2Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2
... American Chemical Society,s (ACS) award-winning " Global Challenges/Chemistry Solutions ... machines seem to be a major source of so-called ... than the head of a pin -- that researchers ... the podcast, Mark Anthony Browne, Ph.D., explains that the ...
... Ill. -- The American Society for Gastrointestinal Endoscopy (ASGE) ... program specifically dedicated to promoting quality in endoscopy, in ... States. The ASGE Endoscopy Unit Recognition Program honors endoscopy ... assurance, endoscope reprocessing and CDC infection control guidelines. To ...
... research hopes to explain premature births and failed inductions of ... Bristol suggests a new mechanism by which the level of ... The researchers, Dr Claire Hudson and Professor Andrs Lpez ... Heesom in the University Proteomics Facility and the School of ...
... Reporter , TUESDAY, Dec. 20 (HealthDay News) -- Sleep problems ... health issues and poorer performance on the job, a new ... from the United States and Canada online or in person ... disorder. The most common problem, suffered by one-third of ...
... use of total hip arthroplasty (THA) and total knee arthroplasty ... postoperative treatment. Aquatic therapy has been shown to have ... after surgery, after the wound has healed. According to ... Medicine and Rehabilitation , beginning aquatic therapy just 6 days ...
... , TUESDAY, Dec. 20 (HealthDay News) -- ... screening to protect all college athletes from sudden death ... a college football player died from complications due to ... mandatory screening of all Division I student athletes. ...
Cached Medicine News:Health News:ASGE recognizes 27 endoscopy units for quality and safety 2Health News:ASGE recognizes 27 endoscopy units for quality and safety 3Health News:Balancing the womb 2Health News:Many Police Officers Battle Sleep Woes, Study Finds 2Health News:Many Police Officers Battle Sleep Woes, Study Finds 3Health News:Aquatic therapy soon after total knee arthroplasty improves outcomes 2Health News:Screening Alone Not Enough to Prevent Sudden Death in College Athletes 2
... SPECIFICATIONS Appearance/Form: White to buff-colored powder Activity: >=590g of ... (A&B): Passes tests Limit of Methanol: Specific Rotation ... pH (4%, H 2 O): 3.5 to 5.5 Loss ... C 1 : 25-50% C 2 + C ...
Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml....
Gentamicin is an aminoglycosidic antibiotic that inhibits bacterial growth by inhibiting protein synthesis. Gentamicin is used for prevention and elimination of bacterial contaminants in cell culture...
1.0% Tryptone, 0.5% yeast extract, 0.5% Sodium Chloride, 0.6% agarose....
Medicine Products: